{
    "nctId": "NCT02975128",
    "briefTitle": "Minimal Invasive Breast Cancer Excision Using the Breast Lesion Excision System Under Ultrasound Guidance",
    "officialTitle": "Minimal Invasive Breast Cancer Excision Using the Breast Lesion Excision System Under Ultrasound Guidance",
    "overallStatus": "TERMINATED",
    "conditions": "Breastcancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 22,
    "primaryOutcomeMeasure": "Frequency of successful complete tumor excision by the BLES system.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* 19 years or older\n* US visible breast cancer with maximum diameter of 15 mm on US\n* Histologically proven invasive breast cancer\n* Willing and able to undergo preoperative breast MRI\n* Able to provide informed consent\n\nExclusion Criteria:\n\n* Poor US visibility of the breast cancer\n* Breast cancer closer than 6 mm to the dermis, nipple or pectoral muscle.\n* Contra-indications to breast MRI or intravenous contrast administration\n* Contra-indications for the use of diathermia\n* Unable to provide informed consent\n* Patients with breast implants\n* Patients with implanted electronics\n* Pregnancy\n* Neoadjuvant chemotherapy",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}